Compare IMNM & CNOBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMNM | CNOBP |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | N/A |
| IPO Year | 2020 | 1995 |
| Metric | IMNM | CNOBP |
|---|---|---|
| Price | $23.93 | $25.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | ★ 847.7K | 3.3K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ 1.51 |
| Revenue | ★ $6,941,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,127.34 | N/A |
| P/E Ratio | ★ N/A | $16.75 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.93 | $23.78 |
| 52 Week High | $30.06 | $25.51 |
| Indicator | IMNM | CNOBP |
|---|---|---|
| Relative Strength Index (RSI) | 39.68 | 52.51 |
| Support Level | $23.67 | $24.87 |
| Resistance Level | $25.07 | $25.48 |
| Average True Range (ATR) | 1.00 | 0.08 |
| MACD | -0.54 | 0.00 |
| Stochastic Oscillator | 15.53 | 45.12 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.